Top Markets
Coin of the day
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Classement en actions #20725
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Prix de l'action
$0.5194
Capitalisation boursière
$125.72M
Changement (1 jour)
-0.12%
Changement (1 an)
48.40%
Pays
US
Échange Vaxart, Inc. (VXRT)

Catégorie

Historique des divisions d’actions pour Vaxart, Inc. (VXRT)
L’action Vaxart, Inc. (symbole : VXRT) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 24, 2026.
Une action VXRT achetée avant le Aug 24, 2026 équivaudrait aujourd’hui à 0 actions VXRT.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH